Connect with us

CivicSciTimes - Stories in Science

A New Beginning: From Bench to Boardroom

When I began my PhD, I was quite certain that I would pursue a research career. But unlike most of my classmates, I was set on going into industry rather than academia.

CSM Lab

Published

on

ย – Suraj Pradhan, PhD –ย 

[su_boxbox title=”About” box_color=”#262733″]Dr. Suraj Pradhan is currently a Senior Manager at BioMarin Pharmaceutical Inc where he monitors the competitive landscape, understands implications for BioMarin, and provides actionable recommendations to guide business strategy. Previously, he was a Senior Associate at Charles River Associates (formerly C1 Consulting). He completed his PhD in Neuroscience at Stanford University. Explore his Linkedin Profile.[/su_boxbox]

[dropcap]W[/dropcap]hen I first heard about the โ€œStories in Scienceโ€ initiative, I was immediately excited by the prospect of reading about the journey of others through science and to have the opportunity to contribute my own story. However, the more I thought about penning my story, the more confused I got about what it was and if it would stand together as a narrative. Over time I realized that my story is still evolving and is a prelude to what I hope will be a rewarding career. In the next few paragraphs I aim to explain how my love for science has evolved, lessons I learned along the way, and how they have led me to the start of a new phase in my journey. As you read through this story keep the following in mind: be open to new possibilities and donโ€™t let opportunities pass you by idly.ย 

Suraj Pradhan

From the time I could start reading, my bookshelves at home were filled with volumes of books on dinosaurs, nature, planets, the human body โ€“ anything that fell within the realm of science. I credit my love of science to those early years which cultivated in me a sense of curiosity and wonder at the world around me. My interest in science at that time was based primarily on my fascination with learning new facts. I did not quite know what to do with those facts, but just reading about them was exhilarating. I discovered that I was good at Biology because I enjoyed learning about it, or perhaps it was the other way around. More often than not, people enjoy the things that they are good at. This combination of interest and skill led me to pursue biochemistry in college. As I delved further though, I started to find biochemistry a little dry with seemingly unending pathways and processes. I wanted to focus on something at a more macro scale and neuroscience seemed to fit the bill. It focused on an organ which was largely unexplored, and its objective was to understand the relationship of micro level circuits/molecules to macro level behavior.

Soon after, neuroscience became my calling and I decided to pursue a PhD to dive deeper into the mysteries of the brain. When I began my PhD, I was quite certain that I would pursue a research career. But unlike most of my classmates, I was set on going into industry rather than academia. This is a topic for another time, but based on what I had read and heard from others, the risk/benefit ratio of pursuing an academic career did not seem worth it to me. As I progressed through my PhD, a few other realizations and events further altered the course of my career.

I realized that research moves at an excruciatingly slow pace and that it takes a huge amount of effort to make even a small dent in the body of knowledge in a field. For me, bench research was proving to be quite isolating and was becoming more tedious by the day. Rather than expanding my knowledge base, a vast amount of my energy was spent refining technical skills in the lab to improve reproducibility of my own results. In the lab, I felt that my research was so far removed from the real world that it would be difficult to measure any impact down the road. Like some of my classmates I started becoming disillusioned with research.

To counter this feeling, I decided to explore a โ€œnewโ€ side of science by getting involved with student groups, taking courses at the business school, and undertaking mini-projects outside of the lab that allowed me to work with biotech industry professionals. I soon discovered that I enjoyed this much more than the actual bench research. It involved greater interaction with people, moved at a faster pace, and allowed me to make a more immediate and tangible impact on the world (this last point was especially important for me). I was naturally drawn to the world of biotech, where decisions made by teams had a very direct impact on the patients who needed their medicines. Considering what I had learned from my experiences in grad school, I decided that a career in the commercialization of drugs would be the best fit for my interests.

When I began my PhD, I was quite certain that I would pursue a research career. But unlike most of my classmates, I was set on going into industry rather than academia.

Unfortunately, no biotech company would hire me on their commercial team straight out of grad school without some sort of full-time experience. I realized that making this type of transition would require additional investment and effort on my part. Luckily a former grad student from my PhD program who is now at Genentech reached out to me about an internship in their Market Analysis and Strategy group. My internship project lasted for about 4 months and involved conducting a competitive landscape analysis and identifying risks and potential opportunities for the company. Although the internship was temporary and compensation was low, it was an invaluable opportunity for two reasons: it was a great experience, further affirming my decision to work in a commercial team in biotech, and it helped me get my foot in the door of biotech.

Explore Next:  Me Versus Me

In the process of mapping out my transition to a full-time role, I sought the advice of my seniors at Genentech. I discovered that, as an intern, almost anyone I approached was willing to mentor me and share their learnings. Based on input from my mentors, I decided to pursue a role in strategy consulting to get a broader exposure to different therapeutic areas. During my two and a half years in consulting, I got the opportunity to work on projects covering all stages of a drugโ€™s lifecycle, worked with teams across large and small biotech companies, and gained a deeper appreciation of the business questions that drive commercial teams. More importantly, I built the necessary set of skills and experience I needed to tackle these business questions using a structured approach. Another key learning for me was that more than the specific therapeutic area, it was the people I worked with and the potential to make a difference that mattered the most to me.

With consulting experience under my belt, I was able to land a full-time position as a Sr. Manager in the competitive intelligence/portfolio strategy team at a biotech company called BioMarin. In my new role, I am far removed from the bench research that characterized my PhD dissertation; however, I am much closer to influencing key business decisions that affect the lives of patients with rare diseases. I am lucky to have found exactly the kind of role that I was looking for with the right balance of science and business, and plenty of opportunity to grow. In some ways, my transition from the bench is over and my real journey to the boardroom has begun.

It is possible that in the future my career will veer in a completely different direction. What is certain is that the diversity of jobs that can benefit from hiring someone with a science background will continue to grow. The challenge for me and for anyone in the sciences will be to determine which job would best fit oneโ€™s interests. In my opinion, the ideal career is one that fulfills 4 basic requirements: you enjoy it and are passionate about it; you’re good at it; it rewards you financially; and it allows you to make a positive impact on the world. If a career meets these criteria, then it will naturally lead to success. To those of you who are in grad school or are looking to make a career transition: my biggest piece of advice would be to find mentors willing to guide you and have a long-term strategy in mind.

Cover image byย Pashminu Mansukhani from Pixabay |ย CC0 Creative Commons

CivicSciTimes - Stories in Science

Unexpected Stories and Spindle Mistakes: Discovering that Wild-type Cells are Full of Surprises

CSM Lab

Published

on

By

Natalie Nannas

Natalie Nannas is an Associate Professor of Biology at Hamilton College in Clinton, NY. She teaches courses in genetics, molecular biology, and bioethics. Dr. Nannas graduated from Grinnell College with bachelor’s degrees in biological chemistry and French. She received her Masterโ€™s and PhD from Harvard University in molecular biology and genetics. Dr. Nannas conducted her postdoctoral research at the University of Georgia where she won a National Science Foundation Plant Genome Postdoctoral Fellowship. At Hamilton College, Dr. Nannas enjoys teaching and sharing her passion for microscopy with her undergraduate research students. When not glued to a microscope, she loves spending time with her husband and two daughters. The narrative below by Natalie Nannas captures the human stories behind the science from a 2022 paper titled โ€œFrequent spindle errors require structural rearrangement to complete meiosis in Zea maysโ€ which was published by her group in 2022 in the International Journal of Molecular Sciences.

Science never works out the way we plan. As scientists, we ask questions, hypothesize and outline our goals โ€ฆ then reality of science occurs. The reality of science is often full of failed controls, endless troubleshooting, and sometimes strange findings that lead us in new and unpredictable directions. Our publications give the impression that we planned these scientific journeys from the beginning and do not tell the human side of the process with all of its twists and turns, dead-ends and U-turns. I want to tell you the real story behind my first publication as a faculty member with my own lab. It did not go as planned due to the COVID-19 pandemic. My lab was shut down in the middle of our investigation, and my students and I were unable to generate new data. In the beginning, it seemed like we were stranded with only control data and no story to tell, but the time away from the lab allowed us to spend more time looking carefully at wild-type cells. What seemed like a dead-end suddenly became its own story when we found something unexpected hiding within microscopy movies. Our wild-type cells were making mistakes, attempting fixes and changing directions, just like we do as scientists.

My scientific journey began with flickering green lights and a microscope (you can read more about it here). As an undergraduate, I was mesmerized by the beauty of watching living cells shuffle fluorescently labeled proteins throughout their cytoplasm. I followed this passion for microscopy into my doctoral dissertation research at Harvard University where I investigated how yeast cells build the machinery needed to pull their chromosomes apart. This machinery is a dynamic collection of long protein tubes called microtubules and other organizing proteins that help move and shuffle microtubules. I loved watching the delicate dance of chromosomes interacting with microtubules of the spindle, and I wanted to continue studying this process in my postdoctoral studies.

During postdoctoral studies at the University of Georgia, I won a fellowship from the National Science Foundation to develop a new technique in microscopy. No one had ever watched plants building their spindles in meiosis, the specialized cell division that produces egg and sperm. Other scientists had performed beautiful microscopy studies observing how mitotic spindles function inside of plant cells, but due to the technical challenges, no one had ever observed live plant cells building spindles in meiosis. I was thrilled to take on this challenge by using version of maize that had fluorescently labeled tubulin, the protein that makes up microtubules of the spindle. With this line of maize, spindles would glow fluorescent green, allowing me to image if only I could extract the meiotic cells.

Dr. Natalie Nannas

We were so busy collecting data and prepping for our mutant studies that we never really took time to analyze the wild-type cells.

After almost a year spent dissecting maize plants, I finally managed to develop a method to isolate these tiny cells and keep them alive in a growth media long enough to image them. This new method of live imaging was going to serve as the foundation of my new lab at Hamilton College, a primarily undergraduate institution. With my students, I planned to investigate the pathways governed spindle assembly. Most animal mitotic cells have a structure called a centrosome that dictates how spindles are formed; however, female animal meiotic cells lack these structures and must use other pathways to direct spindle assembly. Plants also lack centrosomes, and I wanted to inhibit these known animal pathways in our plant live imaging system.

Explore Next:  Ibn Al Haytham: The Father of Modern Optics

As I set up my lab, my students and I collected live movies of wild-type maize cells building their spindles. I told my students and myself that these movies were not the main event, they were just the control cells so we would have a baseline comparison for our experimental conditions. We were so busy collecting data and prepping for our mutant studies that we never really took the time to analyze the wild-type cells. At the surface level, they built spindles and segregated chromosomes in a generally expected amount of time, so we focused on preparing for our upcoming experimentsโ€ฆ. then March 2020 occurred.

The pandemic forced us to slow down and look more carefully at our wild-type data, and I am grateful for the detour.

My students headed home for spring break with a warning that there may be a delay in coming back to campus due to the spread of COVID-19. None of us were prepared for the shutdown that followed. Like many colleges and universities, our campus was closed for the remainder of the spring 2020 semester and the summer of 2020. My students and I began meeting on Zoom, trying to make a new plan for our research. The only data we had to work with were the microscopy of wild-type maize cells, so we decided to spend time digging more deeply into these movies. Originally, we had only measured the total time it took to build a spindle as it would be a baseline for comparison to our mutants. We had not looked carefully at any of the intermediate time points in the assembly process. When my students looked more closely at our movies, they discovered that wild-type cells built an incorrectly shaped spindle over 60% of the time!

We found that maize meiotic cells often built spindles with three poles instead of two, and they had to actively rearrange their spindle structure to correct this mistake. We also found that in these cells, there was a delay in meiosis as cells refused to progress until this correction had been made. This is an exciting discovery as it showed that plants are error-prone in their spindle assembly, much like human female meiotic cells. Our findings also suggested that meiotic cells were monitoring their spindle shape when determining if they should move forward in meiosis. Previous work has shown that cells monitor the attachment of chromosomes to the spindle to make this decision, but our work adds a new dimension, showing that they also monitor spindle shape. As we continued to analyze our videos, we also learned that cells corrected their spindle morphology in a predictable way. They always collapsed the two poles that were closest together, creating a single pole and resulting in a correct bipolar spindle.

The image shows the first page of the paper which can be accessed here.

My students and I had begun our scientific journey planning to breeze over wild-type cells, moving on to what we envisioned would be a more exciting story of spindle mutants. The pandemic forced us to slow down and look more carefully at our wild-type data, and I am grateful for the detour. I rediscovered my love of closely watching flickering green fluorescent lights, the dance of microtubules sliding into place or making missteps and shuffling into new arrangements. Watching life attempt a complicated process, make mistakes, and try again, is a lesson that never grows old. It reminds me that our scientific journeys are just the same, they start in one direction but are fluid and constantly changing, and hopefully, they end with a functional spindle!

Read the Published Paper

Weiss, J.D., McVey, S.L., Stinebaugh, S.E., Sullivan, C.F., Dawe, R.K., and N.J. Nannas. 2022. Frequent spindle errors require structural rearrangement to complete meiosis in Zea maysInternational Journal of Molecular Sciences, 23 (8):4293โ€“4312.

โ€”

ABOUT: Stories in Science is a special series on the Civic Science Times. The main aim is to document the first-hand accounts of the human stories behind the science being published by scientists around the world. Such stories are an important element behind the civic nature of science.

SUBMISSION: Click here to access the story guidelines and submission portal. Please note that not all stories are accepted for publication. After submission, we will let you know whether we have selected the story for the review process.

Continue Reading

Upcoming Events

Trending